
Please try another search
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company’s lead radiotherapeutic candidate is REYOBIQ, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests, such as the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
Name | Age | Since | Title |
---|---|---|---|
Marc H. Hedrick | 62 | 2002 | President, CEO & Director |
Russell Lonser | - | 2020 | Member of Clinical Advisory Board |
Nicholas A. Butowski | - | 2020 | Member of Clinical Advisory Board |
Manish Aghi | - | 2020 | Member of Clinical Advisory Board |
John C. McKew | 61 | 2020 | Member of Scientific Advisory Board |
Michael Vogelbaum | - | 2020 | Member of Clinical Advisory Board |
Howard Clowes | 71 | 2020 | Independent Director |
Alireza Mohammadi | - | 2020 | Member of Clinical Advisory Board |
Kyle Guse | 61 | 2025 | Independent Director |
Richard J. Hawkins | 76 | 2007 | Independent Chairman of the Board |
Robert P. Lenk | 77 | 2020 | Independent Director |
Vladimir P. Torchilin | 78 | 2020 | Member of Scientific Advisory Board |
An van Es-Johansson | 65 | 2020 | Independent Director |
Andrew J. Brenner | - | 2020 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review